I agree that the current quarter should be quite good. However, I do caution that we will probably not get the full starting impact of US FDA approval being reflected in sales until the following (March 08) quarter.
On the other hand, Hawaii placed a respectable order ($150,000) within days of being notified by Cellestis of the FDA approval. That tends to indicate that that they were eagerly standing at the door with their cash in their hand awaiting that approval. I wonder how many others were/are in that queue?
Of course we must not forget Europe. It appears to be going from strength to strength.
CST Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
